Advanced search
Publication Cover
Regenerative Medicine Volume 1, 2006 - Issue 4
Submit an article Journal homepage
383
Views
0
CrossRef citations to date
0
Altmetric
Special Focus: Mesenchymal Stem Cells – Review

3D Scaffolds for Bone Marrow Stem Cell Support in Bone Repair

Samer Srouji1 Anatomy and Cell Biology Department Faculty of Medicine, Technion, HaifaIsrael. +972 4829 5391; Fax: +972 4829 5403;[email protected];2 Oral and Maxillofacial surgery Department, Carmel Medical Center, HaifaFaculty of Medicine, Haifa, IsraelView further author information
,
Tali Kizhner1 Anatomy and Cell Biology Department Faculty of Medicine, Technion, HaifaIsrael. +972 4829 5391; Fax: +972 4829 5403;[email protected]View further author information
&
Erella Livne1 Anatomy and Cell Biology Department Faculty of Medicine, Technion, HaifaIsrael. +972 4829 5391; Fax: +972 4829 5403;[email protected]View further author information
Pages 519-528 | Published online: 18 Jul 2006

Bibliography

  • Owen M , FriedensteinAJ: Stromal stem cells: marrow-derived osteogenic precursors.Ciba Found. Symp.136, 42–60 (1988).
  • Hutmacher DW : Scaffolds in tissue engineering bone and cartilage.Biomaterials21, 2529–2543 (2000).
  • Riminucci M , BiancoP: Building bone tissue: matrices and scaffolds in physiology and biotechnology.Braz. J. Med. Biol. Res.36, 1027–1036 (2003).
  • Petite H , ViateauV, BensaidW et al.: Tissue-engineered bone regeneration. Nat. Biotechnol.18, 959–963 (2000).
  • Service RF : Tissue engineers build new bone.Science289, 1498–1500 (2000).
  • Schaefer D , MartinI, JundtG et al.: Tissue-engineered composites for the repair of large osteochondral defects. Arthritis Rheum.46, 2524–2534 (2002).
  • Fialkov JA , HolyCE, ShoichetMS, DaviesJE: In vivo bone engineering in a rabbit femur.J. Craniofac. Surg.14, 324–332 (2003).
  • Quarto R , MastrogiacomoM, CanceddaR et al.: Repair of large bone defects with the use of autologous bone marrow stromal cells. N. Engl. J. Med.344, 385–386 (2001).
  • Friedenstein AJ , PiatetzkyS, II, Petrakova KV: Osteogenesis in transplants of bone marrow cells. J. Embryol. Exp. Morphol.16, 381–390 (1966).
  • Pittenger MF , MoscaJD, McIntoshKR: Human mesenchymal stem cells: progenitor cells for cartilage, bone, fat and stroma.Curr.Top.Microbiol.Immunol.251, 3–11 (2000).
  • Bianco P , Gehron Robey P: Marrow stromal Stem CellsJ. Clin. Invest.105, 1663–1668 (2000).
  • Bianco P , RiminucciM, GronthosS, RobeyPG: Bone marrow stromal stem cells: nature, biology, and potential applications.Stem Cells19, 180–192 (2001).
  • Bianco P , RobeyPG: Stem cells in tissue engineering.Nature414, 118–121 (2001).
  • Tuan RS , BolandG, TuliR: Adult mesenchymal stem cells and cell-based tissue engineering.Arthritis Res. Ther.5, 32–45 (2003).
  • Abbott A : Cell culture: biology's new dimension.Nature424, 870–872 (2003).
  • Zhang S : Beyond the Petri dish.N. Biotechnol.22, 151–152 (2004).
  • Tuzlakoglu K , BolgenN, SalgadoAJ et al.: Nano- and micro-fiber combined scaffolds: a new architecture for bone tissue engineering. J. Mater. Sci. Mater. Med. 16, 1099–1104 (2005).
  • Liu F , VenturaF, DoodyJ, MassagueJ: Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs.Mol. Cell Biol.15, 3479–3486 (1995).
  • Endres M , HutmacherDW, SalgadoAJ et al.: Osteogenic induction of human bone marrow-derived mesenchymal progenitor cells in novel synthetic polymer-hydrogel matrices. Tissue Eng.9, 689–702 (2003).
  • Hutmacher DW : Scaffold design and fabrication technologies for engineering tissues--state of the art and future perspectives.J. Biomater. Sci. Polym. Ed.12, 107–124 (2001).
  • Lee SC , SheaM, BattleMA et al.: Healing of large segmental defects in rat femurs is aided by RhBMP-2 in PLGA matrix. J. Biomed. Mater.Res.28, 1149–1156 (1994).
  • Ueki K , TakazakuraD, MarukawaK et al.: The use of polylactic acid/polyglycolic acid copolymer and gelatin sponge complex containing human recombinant bone morphogenetic protein-2 following condylectomy in rabbits. J. Craniomaxillofac. Surg.31, 107–114 (2003).
  • Higuchi T , KinoshitaA, TakahashiK, OdaS, IshikawaI: Bone regeneration by recombinant human bone morphogenetic protein-2 in rat mandibular defects. An experimental model of defect filling.J. Periodontol.70, 1026–1031 (1999).
  • Cohn D , SalomonAH: Designing biodegradable multiblock PCL/PLA thermoplastic elastomers.Biomaterials. 26, 2297–2305 (2005).
  • Livingston T , DucheyneP, GarinoJ: In vivo evaluation of a bioactive scaffold for bone tissue engineering.J. Biomed. Mater.Res.62, 1–13 (2002).
  • Arinzeh TL , PeterSJ, ArchambaultMP et al.: Allogeneic mesenchymal stem cells regenerate bone in a critical-sized canine segmental defect. J. Bone Joint Surg. Am.A85, 1927–1935 (2003).
  • Gombotz WR , PankeySC, BouchardLS, PhanDH, PuolakkainenPA: Stimulation of bone healing by transforming growth factor-β 1 released from polymeric or ceramic implants.J. Appl. Biomater.5, 141–150 (1994).
  • Jansen JA : Tissue engineering.Ned Tijdschr Tandheelkd.109, 178–181 (2002).
  • Lind M , OvergaardS, SoballeK et al.: Transforming growth factor-β 1 enhances bone healing to unloaded tricalcium phosphate coated implants: an experimental study in dogs. J. Orthop. Res.14, 343–350 (1996).
  • Bell R , BeirneOR: Effect of hydroxylapatite, tricalcium phosphate, and collagen on the healing of defects in the rat mandible.J. Oral Maxillofac. Surg.46, 589–594 (1988).
  • Bohner M : Calcium orthophosphates in medicine: from ceramics to calcium phosphate cements.Injury31(Suppl. 4), 37–47 (2000).
  • Bohner M , LemaitreJ, MerkleHP, GanderB: Control of gentamicin release from a calcium phosphate cement by admixed poly(acrylic acid).J. Pharm. Sci.89, 1262–1270 (2000).
  • Fleming JE Jr, Cornell CN, Muschler GF: Bone cells and matrices in orthopedic tissue engineering. Orthop.Clin. North Am.31, 357–374 (2000).
  • Schopper C , Ziya-GhazviniF, GoriwodaW et al.: HA/TCP compounding of a porous CaP biomaterial improves bone formation and scaffold degradation--a long-term histological study. J. Biomed. Mater. Res. B. Appl. Biomater.74, 458–467 (2005).
  • Le Guehennec L , LayrolleP, DaculsiG: A review of bioceramics and fibrin sealant.Eur. Cell Mater.8, 1–11 (2004).
  • Chiroff RT , WhiteEW, WeberKN, RoyDM: Tissue ingrowth of Replamineform implants.J. Biomed. Mater.Res.9, 29–45 (1975).
  • White E , ShorsEC: Biomaterial aspects of Interpore-200 porous hydroxyapatite.Dent. Clin. North Am.30, 49–67 (1986).
  • Haddock SM , DebesJC, NaumanEA et al.: Structure-function relationships for coralline hydroxyapatite bone substitute. J. Biomed. Mater.Res.47, 71–78 (1999).
  • Yamamoto M , IkadaY, TabataY: Controlled release of growth factors based on biodegradation of gelatin hydrogel.J. Biomater. Sci. Polym. Ed.12, 77–88 (2001).
  • Yamamoto M , SakakibaraY, NishimuraK, KomedaM, TabataY: Improved therapeutic efficacy in cardiomyocyte transplantation for myocardial infarction with release system of basic fibroblast growth factor.Artif.Organs27, 181–184 (2003).
  • Yamamoto M , TabataY, HongL et al.: Bone regeneration by transforming growth factor β1 released from a biodegradable hydrogel. J. Control. Release64, 133–142 (2000).
  • Li X , JinL, BalianG, LaurencinCT, Greg Anderson D: Demineralized bone matrix gelatin as scaffold for osteochondral tissue engineering. Biomaterials27(11), 2426-2433 (2005).
  • Walsh WR , HarrisonJ, LoeflerA et al.: Mechanical and histologic evaluation of Collagraft in an ovine lumbar fusion model. Clin.Orthop.375, 258–266 (2000).
  • Brodie JC , GoldieE, ConnelG, MerryJ, GrantMH: Osteoblast interactions with calcium phosphate ceramics modified by coating with type I collagen. JBiomed.Mater.Res. A.73, 409–421 (2005).
  • Buckley CT , O'KellyKU: Regular scaffold fabrication techniques for investigations in tissue engineering. In:Topics in Bio-Mechanical Engineering. Prendergast PJ, McHugh PE (Eds). Trinity Centre for Bioengineering & the National Centre for Biomedical Engineering Science, Dublin, Ireland 147–166 (2004).
  • Edwards SL , MitchellW, MatthewsJB, InghamE, RussellSJ: Design of nonwoven scaffold structures for tissue engineering of the anterior cruciate ligament.AUTEX Research Journal4, 86–94 (2004).
  • Salgado AJ , CoutinhoOP, ReisRL: Bone tissue engineering: state of the art and future trends.Macromol.Biosci.4, 743–765 (2004).
  • Eriksson C : Bone morphogenesis and surface charge.Clin.Orthop.Relat.Res.121, 295–302 (1976).
  • Maroudas NG : Sulphonated polystyrene as an optimal substratum for the adhesion and spreading of mesenchymal cells in monovalent and divalent saline solutions.J. Cell Physiol.90, 511–519 (1977).
  • Albrektsson T , JohanssonC: Osteoinduction, osteoconduction and osseointegration.Eur. Spine J.10(Suppl 2), S96–S101 (2001).
  • Lohmann CH , BonewaldLF, SiskMA et al.: Maturation state determines the response of osteogenic cells to surface roughness and 1,25-dihydroxyvitamin D3. J. Bone Miner. Res.15, 1169–1180 (2000).
  • Xie Y , SprouleT, LiY et al.: Nanoscale modifications of PET polymer surfaces via oxygen-plasma discharge yield minimal changes in attachment and growth of mammalian epithelial and mesenchymal cells in vitro. J. Biomed. Mater.Res.61, 234–245 (2002).
  • Campoccia D , ArciolaCR, CervellatiM, MaltarelloMC, MontanaroL: In vitro behaviour of bone marrow-derived mesenchymal cells cultured on fluorohydroxyapatite-coated substrata with different roughness. Biomaterials. 24, 587–596 (2003).
  • Sachlos E , CzernuszkaJT: Making tissue engineering scaffolds work. Review: the application of solid freeform fabrication technology to the production of tissue engineering scaffolds.Eur. Cell Mater.5, 29–39; discussion 39–40 (2003).
  • Rezwan K , ChenQZ, BlakerJJ, BoccacciniAR: Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering.Biomaterials. 27, 3413–3431 (2006).
  • Mikos AG , LymanMD, FreedLE, LangerR: Wetting of poly(L-lactic acid) and poly(DL-lactic-co-glycolic acid) foams for tissue culture.Biomaterials. 15, 55–58 (1994).
  • Mooney DJ , BaldwinDF, SuhNP, VacantiJP, LangerR: Novel approach to fabricate porous sponges of poly(D,L-lactic-co-glycolic acid) without the use of organic solvents.Biomaterials. 17, 1417–1422 (1996).
  • Cima LG , VacantiJP, VacantiC et al.: Tissue engineering by cell transplantation using degradable polymer substrates. J. Biomech. Eng.113, 143–151 (1991).
  • Mikos AG , BaoY, CimaLG et al.: Preparation of poly(glycolic acid) bonded fiber structures for cell attachment and transplantation. J. Biomed. Mater.Res.27, 183–189 (1993).
  • Thomson RC , YaszemskiMJ, PowersJM, MikosAG: Fabrication of biodegradable polymer scaffolds to engineer trabecular bone.J. Biomater. Sci. Polym. Ed.7, 23–38 (1995).
  • Whang K , HealyKE, ElenzDR, et al.: Engineering bone regeneration with bioabsorbable scaffolds with novel microarchitecture. Tissue Eng.5, 35–51 (1999).
  • Schmitz JP , HollingerJO: A preliminary study of the osteogenic potential of a biodegradable alloplastic-osteoinductive alloimplant.Clin.Orthop.Relat.Res.245–255 (1988).
  • Yannas IV , BurkeJF: Design of an artificial skin. I. Basic design principles.J. Biomed. Mater.Res.14, 65–81 (1980).
  • Hollister SJ , LinCY, SaitoE et al.: Engineering craniofacial scaffolds. Orthod.Craniofac.Res.8, 162–173 (2005).
  • Stevens MM , GeorgeJH: Exploring and engineering the cell surface interface.Science310, 1135–1138 (2005).
  • Ratner BD , BryantSJ: Biomaterials: where we have been and where we are going.Annu.Rev. Biomed.Eng.6, 41–75 (2004).
  • Yoshimoto H , ShinYM, TeraiH, VacantiJP: A biodegradable nanofiber scaffold by electrospinning and its potential for bone tissue engineering.Biomaterials. 24, 2077–2082 (2003).
  • Murugan R , RamakrishnaS: Nano-featured scaffolds for tissue engineering: a review of spinning methodologies.Tissue Eng.12, 435–447 (2006).
  • Zussman E , TheronA, YarinAL: Formation of nanofiber crossbars in electrospinning.Applied Physics Letters. 82, 973–975 (2003).
  • Li WJ , LaurencinCT, CatersonEJ, TuanRS, KoFK: Electrospun nanofibrous structure: a novel scaffold for tissue engineering.J. Biomed. Mater.Res.60, 613–621 (2002).
  • Khademhosseini A , LangerR, BorensteinJ, VacantiJP: Microscale technologies for tissue engineering and biology.Proc. Natl Acad. Sci. U.S.A.103, 2480–2487 (2006).
  • Yamada KM : Adhesive recognition sequences.J. Biol. Chem.266, 12809–12812 (1991).
  • Hubbell JA : Biomaterials in tissue engineering.Biotechnology13, 565–576 (1995).
  • Borkenhagen M , ClemenceJF, SigristH, AebischerP: Three-dimensional extracellular matrix engineering in the nervous system.J. Biomed. Mater.Res.40, 392–400 (1998).
  • Bokel C , BrownNH: Integrins in development: moving on, responding to, and sticking to the extracellular matrix.Dev. Cell3, 311–321 (2002).
  • El-Amin SF , KofronMD, AttawiaMA et al.: Molecular regulation of osteoblasts for tissue engineered bone repair. Clin.Orthop.Relat.Res.220–225 (2004).
  • Kroese-Deutman HC , van den Dolder J, Spauwen PH, Jansen JA: Influence of RGD-loaded titanium implants on bone formation in vivo. Tissue Eng.11, 1867–1875 (2005).
  • Kim TG , ParkTG: Biomimicking Extracellular Matrix: Cell Adhesive RGD Peptide Modified Electrospun Poly(D,L-lactic-co-glycolic acid) Nanofiber Mesh.Tissue Eng.12, 221–233 (2006).
  • Canalis E , CentrellaM, McCarthyT: Effects of basic fibroblast growth factor on bone formation in vitro.J. Clin. Invest.81, 1572–1577 (1988).
  • Canalis E , McCarthyT, CentrellaM: A bone-derived growth factor isolated from rat calvariae is β 2 microglobulin.Endocrinology121, 1198–1200 (1987).
  • Canalis E , McCarthyT, CentrellaM: Growth factors and the regulation of bone remodeling.J. Clin. Invest.81, 277–281 (1988).
  • Canalis E , McCarthyT, CentrellaM: Isolation of growth factors from adult bovine bone.Calcif.Tissue Int.43, 346–351 (1988).
  • Canalis E , McCarthyTL, CentrellaM: The role of growth factors in skeletal remodeling.Endocrinol.Metab.Clin. North Am.18, 903–918 (1989).
  • Joyce ME , JingushiS, ScullySP, BolanderME: Role of growth factors in fracture healing.Prog.Clin.Biol. Res.365, 391–416 (1991).
  • Bonewald LF , MundyGR: Role of transforming growth factor-β in bone remodeling.Clin.Orthop.250, 261–276 (1990).
  • Mohan S , BaylinkDJ: Bone growth factors.Clin.Orthop.263, 30–48 (1991).
  • Lind M : Growth factors: possible new clinical tools. A review.Acta.Orthop.Scand.67, 407–417 (1996).
  • Lind M , OvergaardS, OngpipattanakulB et al.: Transforming growth factor-β 1 stimulates bone ongrowth to weight-loaded tricalcium phosphate coated implants: an experimental study in dogs. J. Bone Joint Surg. Br.78, 377–382 (1996).
  • Varkey M , GittensSA, UludagH: Growth factor delivery for bone tissue repair: an update.Expert Opin.Drug Deliv.1, 19–36 (2004).
  • Martin TJ , NgKW, NicholsonGC: Cell biology of bone.Baillieres Best Pract. Res. Clin. Endocrinol.Metab.2, 1–29 (1988).
  • Urist MR : Bone: formation by autoinduction.Science150, 893–899 (1965).
  • Urist MR , StratesBS: Bone morphogenetic protein.J. Dent. Res.50, 1392–1406 (1971).
  • Ducy P , KarsentyG: The family of bone morphogenetic proteins.Kidney Int.57, 2207–2214 (2000).
  • Asahina I , SampathTK, NishimuraI, HauschkaPV: Human osteogenic protein-1 induces both chondroblastic and osteoblastic differentiation of osteoprogenitor cells derived from newborn rat calvaria.J. Cell Biol.123, 921–933 (1993).
  • Hughes FJ , CollyerJ, StanfieldM, GoodmanSA: The effects of bone morphogenetic protein-2, -4, and -6 on differentiation of rat osteoblast cells in vitro.Endocrinology136, 2671–2677 (1995).
  • Okubo Y , BesshoK, FujimuraK, IizukaT, MiyatakeS: Expression of bone morphogenetic protein-2 via adenoviral vector in C2C12 myoblasts induces differentiation into the osteoblast lineage.Biochem.Biophys. Res. Commun.262, 739–743 (1999).
  • Groeneveld EH , BurgerEH: Bone morphogenetic proteins in human bone regeneration.Eur. J. Endocrinol.142, 9–21 (2000).
  • Duguy N , PetiteH, ArnaudE: Biomaterials and osseous regeneration.Ann. Chir. Plast.Esthet.45, 364–376 (2000).
  • Ames CP , NottmeierEW, DickmanCA, VKHS: Targeted Tissue Engineering in Spinal Surgery, The Bone Morphogenetic Proteins: Past, Present Future,BNI Quarterly19(1), 4–16 (2003).
  • Srouji S , Blumenfeld,I., Rachmiel A., and Livne: Bone defectosteoinduction in rat tibia by TGF- and IGF-1 released from a biodegradable hydrogel. Cell Tissue Bank. (2004).
  • Srouji S , Rachmiel.A, Livne,E.,: Induction of mandibule defect repair by TGF- and IGF-I released from Biodegradable osteoconduction hydrogel. Cranio-MaxillofacSurg. (2004).
  • Augat P , MargeviciusK, SimonJ et al.: Local tissue properties in bone healing: influence of size and stability of the osteotomy gap. J. Orthop. Res.16, 475–481 (1998).
  • Blumenfeld I , SroujiS, PeledM, LivneE: Metalloproteinases (MMPs -2, -3) are involved in TGF-β and IGF-1-induced bone defect healing in 20-month-old female rats.Arch. Gerontol. Geriatr.35, 59–69 (2002).
  • Blumenfeld I , SroujiS, LanirY, LauferD, LivneE: Enhancement of bone defect healing in old rats by TGF-β and IGF-1.Exp. Gerontol.37, 553–565 (2002).
  • Kneser U , SchaeferDJ, PolykandriotisE, HorchRE: Tissue engineering of bone: the reconstructive surgeon's point of view.J. Cell Mol. Med.10, 7–19 (2006).
  • Wong C , InmanE, SpaetheR, HelgersonS: Fibrin-based Biomaterials to deliver human growth factors.Thromb.Haemost.89, 573–582 (2003).
  • Wenger A , StahlA, WeberH et al.: Modulation of in vitro angiogenesis in a three-dimensional spheroidal coculture model for bone tissue engineering. Tissue Eng.10, 1536–1547 (2004).
  • Putney SD , BurkePA: Improving protein therapeutics with sustained-release formulations.Nat. Biotechnol.16, 153–157 (1998).
  • Luginbuehl V , MeinelL, MerkleHP, GanderB: Localized delivery of growth factors for bone repair.Eur. J. Pharm. Biopharm.58, 197–208 (2004).
  • Edelman ER , MathiowitzE, LangerR, KlagsbrunM: Controlled and modulated release of basic fibroblast growth factor.Biomaterials. 12, 619–626 (1991).
  • Sakiyama-Elberta SE , HubbellJA: Development of fibrin derivatives for controlled release of heparin-binding growth factors.J. Control. Release65, 389–402 (2000).
  • Wissink MJ , BeerninkR, ScharenborgNM et al.: Endothelial cell seeding of (heparinized) collagen matrices: effects of bFGF pre-loading on proliferation (after low density seeding) and pro-coagulant factors. J. Control. Release67, 141–155 (2000).
  • Mann BK , SchmedlenRH, WestJL: Tethered-TGF-β increases extracellular matrix production of vascular smooth muscle cells.Biomaterials. 22, 439–444 (2001).
  • Jin QM , AnusaksathienO, WebbSA, RutherfordRB, GiannobileWV: Gene therapy of bone morphogenetic protein for periodontal tissue engineering.J. Periodontol.74, 202–213 (2003).
  • Schek RM , TaboasJM, SegvichSJ, HollisterSJ, KrebsbachPH: Engineered osteochondral grafts using biphasic composite solid free-form fabricated scaffolds.Tissue Eng.10, 1376–1385 (2004).
  • Schek RM , WilkeEN, HollisterSJ, KrebsbachPH: Combined use of designed scaffolds and adenoviral gene therapy for skeletal tissue engineering.Biomaterials. 27, 1160–1166 (2006).
  • Botchwey EA , PollackSR, LevineEM, LaurencinCT: Bone tissue engineering in a rotating bioreactor using a microcarrier matrix system.J. Biomed. Mater.Res.55, 242–253 (2001).
  • Meinel L , KarageorgiouV, FajardoR et al.: Bone tissue engineering using human mesenchymal stem cells: effects of scaffold material and medium flow. Ann. Biomed.Eng.32, 112–122 (2004).
  • Sikavitsas VI , TemenoffJS, MikosAG: Biomaterials and bone mechanotransduction.Biomaterials. 22, 2581–2593 (2001).
  • Franceschi RT , XiaoG: Regulation of the osteoblast-specific transcription factor, Runx2: responsiveness to multiple signal transduction pathways.J. Cell Biochem.88, 446–454 (2003).
  • Wang DA , WilliamsCG, YangF et al.: Bioresponsive phosphoester hydrogels for bone tissue engineering. Tissue Eng.11, 201–213 (2005).
  • Lee YM , SeolYJ, LimYT et al.: Tissue-engineered growth of bone by marrow cell transplantation using porous calcium metaphosphate matrices. J. Biomed. Mater.Res.54, 216–223 (2001).
  • Chen F , MaoT, TaoK et al.: Bone graft in the shape of human mandibular condyle reconstruction via seeding marrow-derived osteoblasts into porous coral in a nude mice model. J. Oral Maxillofac. Surg.60, 1155–1159 (2002).
  • Nunamaker DM : Experimental models of fracture repair.Clin.Orthop.Relat. Res.S56–S65 (1998).
  • Schantz JT , HutmacherDW, ChimH et al.: Induction of ectopic bone formation by using human periosteal cells in combination with a novel scaffold technology. Cell Transplant.11, 125–138 (2002).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.